Summary
TN8 Chart
TMO Launches Next-Generation Mass Spectrometers: Stock to Gain?
Thermo Fisher debuts two advanced MSs, Orbitrap Astral Zoom and Orbitrap Excedion Pro, to accelerate precision medicine and drug discovery breakthroughs.
Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?
The neutral DCF model implemented in this article suggests that Thermo Fisher is undervalued by 29.24%. Thermo Fisher has invested, on average, 16.51% of its revenues in capex between 2019 and 2024. Due to the significant investment in capex, Thermo Fisher's revenues have increased at a 12.95% CAGR between 2019 and 2024.
Thermo Fisher Is Strengthening Its Long-Term Advantage
Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary, not reflective of structural weakness in its fundamentals. The company is mitigating trade impacts by investing $2B in US manufacturing, leveraging diversification and innovation, and expects headwinds to peak this year. Biopharma growth, strategic acquisitions, and rapid product innovation position TMO for long-term outperformance versus less diversified peers.
Thermo Fisher Scientific Inc. Dividends
 TN8 2 months ago | Other | €0.38 Per Share |
| TN8 5 months ago | Other | €0.34 Per Share |
| TN8 8 months ago | Other | €0.34 Per Share |
| TN8 11 months ago | Other | €0.34 Per Share |
| TN8 14 Mar 2024 | Other | €0.34 Per Share |
Thermo Fisher Scientific Inc. Earnings
| 22 Jul 2025 (49 Days) Date | | - Cons. EPS | - EPS |
| 23 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Apr 2025 Date | | - Cons. EPS | - EPS |
| 31 Jan 2025 Date | | - Cons. EPS | - EPS |
| 23 Oct 2024 Date | | - Cons. EPS | - EPS |
| TN8 2 months ago | Other | €0.38 Per Share |
| TN8 5 months ago | Other | €0.34 Per Share |
| TN8 8 months ago | Other | €0.34 Per Share |
| TN8 11 months ago | Other | €0.34 Per Share |
| TN8 14 Mar 2024 | Other | €0.34 Per Share |
| 22 Jul 2025 (49 Days) Date | | - Cons. EPS | - EPS |
| 23 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Apr 2025 Date | | - Cons. EPS | - EPS |
| 31 Jan 2025 Date | | - Cons. EPS | - EPS |
| 23 Oct 2024 Date | | - Cons. EPS | - EPS |
Thermo Fisher Scientific Inc. (TN8) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Thermo Fisher Scientific Inc. ever had a stock split?
Thermo Fisher Scientific Inc. Profile
| Medical - Diagnostics & Research Industry | Healthcare Sector | Mr. Marc N. Casper CEO | XMUN Exchange | US8835561023 ISIN |
| US Country | 125,000 Employees | 13 Jun 2025 Last Dividend | 6 Jun 1996 Last Split | 13 Jan 1978 IPO Date |
Overview
Thermo Fisher Scientific Inc. is a global leader in serving science, offering a wide range of products and services across life sciences, analytical instruments, specialty diagnostics, and laboratory products, as well as biopharma services. The company boasts a broad presence, serving customers in North America, Europe, the Asia-Pacific region, and internationally. Its offerings are designed to cater to the needs of the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. By delivering solutions that support research and development, diagnostics, and the production of drugs and vaccines, Thermo Fisher Scientific plays a pivotal role in advancing public health and scientific endeavors worldwide. Founded in 1956, the company is headquartered in Waltham, Massachusetts.
Products and Services
- Life Sciences Solutions
This segment provides a variety of reagents, instruments, and consumables used in biological and medical research, the discovery and production of drugs and vaccines, and the diagnosis of infections and diseases. The offerings encompass biosciences, genetic sciences, and bio production and are tailored for markets including pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government sectors.
- Analytical Instruments
Includes instruments, consumables, software, and services suited for a wide range of applications in the pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. These instruments and services facilitate complex analyses and experiments.
- Specialty Diagnostics
This segment offers a variety of diagnostic products and services, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments. It covers the needs of the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; provides human leukocyte antigen typing and testing for the organ transplant market; and supplies healthcare products.
- Laboratory Products and Biopharma Services
Provides an extensive array of laboratory products and services, including research and safety market channel and pharma services and clinical research, catering to various scientific needs. The segment supports the research, development, and production processes across the scientific community.
The company offers these products and services through a combined approach of a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon and PPD brands.
Contact Information
